Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Woodruff-Pak, Diana S.a; * | Agelan, Alexisb | Valle, Luis Delc
Affiliations: [a] Department of Psychology, Temple University and Departments of Neurology & Radiology, School of Medicine, Philadelphia, PA, USA | [b] University Laboratory Animal Resources, Temple University, School of Medicine, Philadelphia, PA, USA | [c] Department of Neuroscience & Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA
Correspondence: [*] Corresponding author: Diana S. Woodruff-Pak, Ph.D., Department of Psychology, 1701 North 13th Street, Temple University, Philadelphia, PA 19122, USA. Tel.: +1 215 204 1258; Fax: +1 215 204 5539; E-mail: [email protected].
Abstract: Supplementing a rabbit's diet with 2% cholesterol alone or with a trace amount of copper created neuropathological changes that resembled those seen in Alzheimer's disease (AD). AD model rabbits were impaired in eyeblink classical conditioning; a form of learning severely impaired in AD. Our aim was to replicate AD rabbit model neuropathology, test eyeblink conditioning in this model, and determine if galantamine (Razadyne™) would ameliorate impaired conditioning. In Experiment 1 rabbit chow with 2% cholesterol and drinking water with 0.12 mg/liter copper sulfate were administered for 10 weeks. Control rabbits received normal food and water. Rabbit brains were probed for neuropathology. AD model rabbits had significant neuronal loss in frontal cortex, hippocampus and cerebellum. Changes in neurons in the hippocampus were consistent with neurofibrillary degeneration and cytoplasmic immunoreactivity for amyloid-β and tau. In Experiment 2 AD model rabbits were injected daily with vehicle or 3.0 mg/kg galantamine and tested on 750 ms trace and delay eyeblink conditioning. Galantamine improved eyeblink conditioning significantly over vehicle. The AD rabbit model has validity from neuropathological to cognitive levels and offers a promising addition to the available animal models of AD. Galantamine ameliorated impaired eyeblink conditioning, extending the validity of the AD rabbit model to treatment modalities.
Keywords: Eyeblink classical conditioning, trace paradigm, delay paradigm, amyloid-β, tau, neuronal loss, hippocampus, cerebral cortex, cerebellum
DOI: 10.3233/JAD-2007-11313
Journal: Journal of Alzheimer's Disease, vol. 11, no. 3, pp. 371-383, 2007
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]